Tiny implantable 'seeds' of tissue produce fully functional livers
24 July, 2017 by Anne Trafton, MIT News OfficeIn an effort to ease the shortage of livers, US researchers have developed a new way to engineer liver tissue by organising tiny subunits that contain three types of cells embedded into a biodegradable tissue scaffold.
Ebola-fighting super cell discovered
18 July, 2017Australian and American researchers have discovered a super cell that may have the potential to help contain the Ebola virus.
Gut flora an early marker for heart failure?
14 July, 2017In the gut of patients with heart failure, important groups of bacteria are found less frequently and the gut flora is not as diverse as in healthy individuals.
Mother's epigenetic memory essential for embryo development and survival
14 July, 2017It has long been debated if epigenetic modifications accumulated throughout the entire life can cross the border of generations and be inherited by children or even grandchildren.
Gonorrhoea resistance on the rise; new drugs needed
07 July, 2017Each year around 78 million people are infected with gonorrhoea, a common sexually transmitted infection.
Personalised vaccine prompts strong anti-tumour response in patients
06 July, 2017A personal cancer treatment vaccine that targets distinctive 'neoantigens' on tumour cells has been shown to stimulate a potent, safe and highly specific immune anti-tumour response in melanoma patients, reported scientists from Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard.
Australian-Canadian partnership for medical cannabis
04 July, 2017LeafCann Group, a Melbourne-based medical cannabis producer, has formed a joint venture with Canadian developer of medical cannabis delivery systems and devices Resolve Digital Health.
Skin cancer costs 30 times more to treat than prevent
03 July, 2017Despite being largely preventable, skin cancer costs Victoria's public hospitals more than $50 million a year, new research from Deakin University and Cancer Council Victoria has found.
Aus cancer vaccine closer to human trials
30 June, 2017Radvax, a cancer treatment vaccine, being developed by South Australian company Vaxine, is closer to human trials.
Cancer cells may streamline their genomes to replicate faster
26 June, 2017A recent study, conducted in both human and mouse cells, has revealed that cancer cells might streamline their genomes in order to proliferate more easily.
New approach examines how medicines act on cells
19 June, 2017Australian researchers have developed a new approach to monitor how medicines interact with and modify the activity of living cells.
New initiatives to prevent pests
07 June, 2017The NSW Government will continue its involvement in collaborative invasive species research and innovation under the new Centre for Invasive Species Solutions, while the Plant Biosecurity CRC is celebrating a win for its Pestpoint software at Collaborate | Innovate 2017.
'Turning off' allergies
05 June, 2017 by Adam FloranceResearchers are one step closer to a treatment that could 'turn off' the immune response that causes common allergies, including asthma — which affects over two million Australians.
Staying clinically competitive
05 June, 2017 by Mansi GandhiCost-competitiveness, high-quality data and fast study start-up times are some of the key factors that make Australia an attractive market for clinical trials. But as other countries strive to improve their clinical competitiveness, can Australia hold a dominant position?
